Antonio Jimeno, MD, PhD (IMAGE)
Caption
Antonio Jimeno, MD, PhD, leads a team describing the basic biology and potential future uses of the drug SVC112
Credit
University of Colorado Cancer Center
Usage Restrictions
None
License
Licensed content